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Background: Retention of a subset of introns in spliced polyadenylated mRNA is emerging as a frequent,
unexplained finding from RNA deep sequencing in mammalian cells.
Results: Here we analyze intron retention in T lymphocytes by deep sequencing polyadenylated RNA. We show a
developmentally regulated RNA-binding protein, hnRNPLL, induces retention of specific introns by sequencing RNA
from T cells with an inactivating Hnrpll mutation and from B lymphocytes that physiologically downregulate Hnrpll
during their differentiation. In Ptprc mRNA encoding the tyrosine phosphatase CD45, hnRNPLL induces selective
retention of introns flanking exons 4 to 6; these correspond to the cassette exons containing hnRNPLL binding sites
that are skipped in cells with normal, but not mutant or low, hnRNPLL. We identify similar patterns of hnRNPLL-
induced differential intron retention flanking alternative exons in 14 other genes, representing novel elements of
the hnRNPLL-induced splicing program in T cells. Retroviral expression of a normally spliced cDNA for one of these
targets, Senp2, partially corrects the survival defect of Hnrpll-mutant T cells. We find that integrating a number of
computational methods to detect genes with differentially retained introns provides a strategy to enrich for
alternatively spliced exons in mammalian RNA-seq data, when complemented by RNA-seq analysis of purified cells
with experimentally perturbed RNA-binding proteins.
Conclusions: Our findings demonstrate that intron retention in mRNA is induced by specific RNA-binding proteins
and suggest a biological significance for this process in marking exons that are poised for alternative splicing.Background
Splicing of introns from pre-messenger RNA is a tightly
regulated process performed by the spliceosome [1]. The
assembly of the spliceosome at appropriate exon-intron
boundaries is influenced by regulatory RNA-binding pro-
teins (RBPs) that operate antagonistically to both enhance
and repress this splicing machinery [2-4]. Heterogeneous
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unless otherwise stated.perform a splicing repressor function and their binding
blocks spliceosome assembly and leads to exclusion of
exons from mature mRNAs. Serine/arginine-rich (SR) pro-
teins bind enhancer sequences in RNA and promote asso-
ciation of spliceosomal proteins at splice sites. This general
model nevertheless requires testing in physiological experi-
mental systems where developmentally regulated splicing
factors are specifically perturbed, but few such systems
have been described, especially for mammalian cells.
Recent information has identified that transcription
and splicing are functionally coupled, allowing cross-talk
between the two processes [5]. Co-transcriptional assem-
bly of the spliceosome on nascent, chromatin-associated
RNA transcripts is a significant factor in correct gene
regulation in yeast [6], Drosophila [7] and mammals. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ciate with chromatin-associated nascent RNA in human
HeLa cells [11] and slowing the rate of RNA polymerase
II transcription in Drosophila greatly increases the rate
of alternative exon inclusion [12]. High-throughput se-
quencing of chromatin-associated, nascent RNA in Dros-
ophila has revealed that the majority of introns are
co-transcriptionally spliced at least half of the time,
though a minority of introns are spliced slowly and some
appear never to be co-transcriptionally spliced [7]. This
variability in co-transcriptional splicing efficiency occurs
even within single transcripts and suggests that splicing
is regulated at the level of the intron [7], presumably by
different RBPs such as the hnRNPs and SR proteins. In-
trons that are consistently identified to be resistant to
co-transcriptional splicing correlate with annotated al-
ternative exons [7,9,13].
To understand mammalian alternative splicing, and de-
fine the relationship between variable intron retention after
transcription and alternative splicing, it would be useful to
be able to experimentally perturb developmentally regu-
lated alternative splicing events through genetic mutations
in the specific RBPs that control them. One of the best de-
fined mammalian alternative splicing events occurs in the
Ptprc gene encoding the major plasma membrane tyrosine
phosphatase, CD45, in T lymphocytes and other blood leu-
kocytes [4,14]. In memory T cells that have been activated
previously by antigens, exons 4, 5 and 6 are skipped in the
translated Ptprc mRNA. The resulting loss of the CD45-
RA, RB and RC domains in the extracellular domain of
the protein, detected by flow cytometric staining with
specific antibodies, is used as the primary marker to differ-
entiate memory T cells and activated T cells (CD45-RO+)
from naïve T cells (CD45-RA+ or CD45-RB+). Even in
naïve T cell mRNA all three Ptprc cassette exons are rarely
included whereas they are all included in B lymphocyte
Ptprc mRNA, resulting in the CD45R-ABC isoform
(B220) that is detected by specific monoclonal antibodies
to identify B cells.
Silencing of Ptprc exons 4, 5 and 6 in T cells requires
hnRNPLL, a protein with three RNA-recognition motif
(RRM) domains whose mRNA expression correlates
with Ptprc exon exclusion: it is highest in CD45RO+ ac-
tivated and memory T cells that exclude exons 4 to 6, at
intermediate levels in CD45RB+ naïve T cells, and at very
low levels in CD45RABC+ B cells that include all three
exons [15-17]. Mice homozygous for a destabilizing
point mutation in the amino-terminal RRM domain,
Hrnpllthu, fail to exclude exons 4, 5, and 6 in T-cell Ptprc
mRNA and expression of CD45-RA and CD45-RC pro-
tein isoforms are increased 50-fold on different T-cell
subsets [16]. Likewise, increased inclusion of Ptprc exons
4 to 6 occurs when hnRNPLL is depleted from human T
cells by short hairpin RNA (shRNA) expression, whilesilencing of Ptprc exon 4 is induced in human T cells
transfected to overexpress Hnrpll cDNA [15,17]. The
isolated amino-terminal RRM domain normally binds
with sequence specificity and micromolar affinity [16] to
an RNA consensus sequence, the activation response se-
quence (ARS), which mediates exon silencing in acti-
vated T cells and occurs in each of Ptprc exons 4, 5 and
6 [18]. Thus, hnRNPLL is a developmentally regulated
Ptprc splicing silencer whose expression and activity are
critical for the regulated changes in CD45 isoforms on T
and B lymphocytes.
A closely related protein, hnRNPL, has also been
shown to bind Ptprc ARS RNA sequences present in
exons 4 to 6 [19,20]. T cells from mice homozygous for
a knockout of the Hnrpl gene have moderately increased
inclusion of exons 4 and 6, resulting in a four-fold in-
crease in CD45RA expression [21]; compared with a 50-
fold increase caused by Hnrpll mutation. Thus, hnRNPL
and hnRNPLL both contribute to exon silencing but
their coordinated actions are only partly understood [4].
The interphase lifespan of Hrnpllthu homozygous T cells
is greatly shortened, resulting in decreased numbers of
naïve T cells in the circulation [16]. This effect of
hnRNPLL deficiency occurs even in T cells with a null
Ptprc gene [22], indicating that hnRNPLL controls other
genes contributing to T cell persistence that have yet to be
identified. Here we use this mammalian system to analyze
the consequences of perturbing hnRNPLL either by muta-
tion or natural expression differences, as revealed by glo-
bal mRNA changes measured by RNA-seq. hnRNPLL was
required to induce a distinct pattern of intron retention
surrounding its known target cassette exons in Ptprc. Dif-
ferential retention of introns in deeply sequenced RNA
provided a signature that could be used to identify other
mRNAs requiring hnRNPLL for correct splicing in T cells,
and this represents a general, albeit not completely spe-
cific, strategy to annotate the transcriptome for exons that
are likely to undergo differential splicing.
Results
Alternative introns are differentially retained in Ptprc
transcripts
In a mouse genetic screen we previously identified
hnRNPLL as an essential regulatory factor responsible for
skipping of Ptprc exons 3, 4 and 5 in T cells. Thunder mice
have a loss-of-function point mutation in the Hnrpll gene
that destabilizes the amino-terminal ARS-binding RRM
domain of hnRNPLL [16]. To analyze the consequences
of Hnrpllthu upon T-cell mRNA splicing, we performed
RNA-seq on mRNA isolated from CD8+ T lymphocytes
purified from transgenic OT-1 T-cell receptor (TCR) mice
that were either wild type or homozygous for Hrnpllthu.
The OT-1 TCR transgenes possessed by this mouse pro-
vided a uniform T cell antigen receptor on the CD8+
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peptide and ensured that most of the cells were antigeni-
cally naïve. This resulted in comparable frequencies of
naïve and memory T cells in the Hrnpllthu animals and the
wild-type controls, enabling the analysis to focus on the
primary effects of the mutation on splicing and minimize
the contribution of Hnrpll-independent differences in
mRNA splicing between naïve and memory T cells.
RNA-seq was performed on biologically independent
replicate samples starting with RNA purified from T cells
and using oligo-dT to prime first strand cDNA synthesis.
The resulting libraries were each sequenced to a depth of
greater than 100 million single-end 125 bp reads on an
Illumina GAIIx sequencer, and aligned to the mouse gen-
ome (mm9) using TopHat with Bowtie [23]. To confirm
that the majority of aligned sequence data came from
spliced polyadenylated mRNA, we compared the ratio of
intronic reads to exonic reads. For each intron in the
9,162 genes expressed at more than a mean of 20 reads
per exonic nucleotide, we calculated the number of reads
in the last 25 bp of each intron and divided it by the num-
ber of reads in the adjacent first 25 bp of the exon, to yield
the ratio of reads across the 3′ splice site (3′SS ratio [7,9])
(Figure 1). This showed that almost all mRNAs are com-
pletely spliced with a mode of the intron retention less
than 0.01 and a median of 0.019.
The Ptprc gene contains 33 exons spanning 112 kb on
chromosome 1 (Figure 2a), and is highly expressed in T
cells with a median of >3,300 reads per exonic nucleo-
tide in each of our CD8 T-cell RNA-seq datasets. The
majority of Ptprc introns were spliced out of 99% of the
sequenced RNA, as illustrated by the large difference in
read coverage over constitutive exons 9 to 29 compared0
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Figure 1 Most transcripts in wild-type and thunder CD8+ T cells are full
wide distribution of intron splicing frequency is skewed towards full removal
intron retention). The majority of introns (87%) have a splicing efficiency of gr
polyadenylated mRNAs; 0.94% of introns have a splicing efficiency of less than
present in our RNA-seq data.to the intervening introns (Figure 2b) and by a median
3′SS ratio of 0.01 for Ptprc introns as a whole. In wild-
type CD8+ cells (CD45-RBhigh, RAlow and RBlow) there
was strong silencing of exons 4 and 6, which contain
multiple ARS, whereas the more abundant exon 5, en-
coding the CD45-RB isoform, was better represented in
sequence reads. The hnRNPLL-dependence of this dif-
ferential splicing is readily apparent from Figure 2c - the
two wild-type T cell samples had a mean of 777 and
1,639 reads per nucleotide in exons 4 and 6, respectively,
compared with a mean of 3,735 for all Ptprc exons,
whereas in the Hnrpllthu T cells exon 4 and 6 were cov-
ered by a mean of 2,747 and 3,766, respectively, com-
pared to a mean of 3,766 for all Ptprc exons.
Surprisingly, an abundance of reads was also observed
in wild-type T cells selectively over Ptprc introns 3, 4, 5,
6 and 7 compared with the other introns in the gene.
The median read depths over introns 3, 4, 5, 6 and 7
were 310, 366, 746, 759 and 552 reads, respectively, and
were significantly higher (P = 1.6 × 10-4, Mann-Whitney,
W = 200) than the mean depths over all other introns
(median read depth of 16). Mutant Hnrpllthu cells also
showed significantly increased reads in the same introns,
though at a universally lower level than wild-type cells.
Hence, wild-type CD8+ T cells display a greater depth of
intronic reads and inversely fewer exonic reads relative
to mutant cells through the region of the Ptprc tran-
script known to undergo alternative splicing. The me-
dian read depth over these retained introns in wild-type
cells is between 8 to 20% as abundant as sequence reads
over all Ptprc exons. This indicates that, in wild-type
CD8+ T cells, approximately 8 to 20% of the sequenced
Ptprc mRNA had not yet removed either exon 4 and10
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Figure 2 Increased intron retention in wild-type T cells correlates with exon-skipping events in Ptprc. (a) Exons 4, 5 and 6 of the Ptprc
(CD45) gene are alternatively spliced in T cells and may be combined to produce eight distinct CD45 isoforms. The longest isoform, CD45RABC, is
primarily expressed in B cells whereas T cells express different CD45 isoforms through their development and activation. (b) RNA-seq data along
the length of the Ptprc gene show the introns flanking alternative exons 4, 5 and 6 are covered by a greater depth of sequence reads and
indicates incomplete splicing of these introns in both wild-type (WT; in red) and thunder (THU; in blue) CD8+ T cells. (c) Read depth over retained
introns is consistent within biological replicate samples, but is different between wild-type (red) and thunder (blue) samples, as shown in the
purple trace, which plots the wild-type minus thunder per nucleotide read depth through the alternatively spliced region of the Ptprc gene.
Introns and exons are labeled as I- and E-, respectively, followed by their corresponding number. Thunder mutants with a hypomorphic Hnrpll
gene show fewer reads aligned to introns 3, 4, 5, 6 and 7.
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http://genomebiology.com/2014/15/1/R26exon 6 nor the introns that precede and follow these
exons, yet 99% of the sequenced Ptprc mRNA had re-
moved constitutively spliced introns. It is important to
note that deep sequencing of RNA provides a unique
opportunity to measure mammalian intron retention ina relatively unbiased manner, in contrast to PCR-based
methods that are biased against detecting the very large
intronic inserts.
As an independent test of the effect of diminished
hnRNPLL activity on lymphocyte mRNA splicing and
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magnetic-bead enriched CD4+ T cells (Hnrpll-high) and
CD19+ B-cells (Hnrpll-low) (Figure 3a). As expected for
bead-based enrichment methods, the B-cell-enriched
samples still contained an estimated 7% T cells based on
mean expression of a set of T-cell-specific mRNAs,de
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B cells express very little hnRNPLL. In CD4+ T cells,
which do express hnRNPLL, the read depth over exons
4 and 6 was lower (median 130) than the median
depth over Ptprc exons as a whole (192), confirming
silencing of these exons. A reciprocal pattern was ob-
served for the introns flanking exons 4 to 6, where
there was a higher depth of reads in T cells (median of
54) and a lower depth of reads in B cells (median of
23). Hence, B cells with naturally low Hnrpll expres-
sion splice out introns 4 to 6 more efficiently than T
cells that express Hnrpll.
As further evidence of differential intron retention be-
tween T and B cells, we analyzed RNA-seq data gener-
ated by the ImmGen project [24] from polyadenylated
mRNA isolated from highly purified CD4+ T cells and
CD19+ B cells prepared using fluorescence-activated cell
sorting (Figure 3b) [25]. Ptprc introns 4 to 6 exhibited
numerous reads in T cells, with a median of 144 com-
pared to 1,655 for all Ptprc exons. By contrast, very few
intron 4 to 6 reads were obtained from B-cell mRNA,
with a read depth of 5 compared to a median of 1,071
for all Ptprc exons in the same sample. This indicates
that introns 4 through 6 are efficiently spliced out of
99.5% of Ptprc mRNA in B cells that have little
hnRNPLL, but are retained in 9% of the corresponding
mRNA from CD4 T cells.
Retained introns are frequent and correlate with
alternatively spliced exons
Given the findings above, we asked how many other
mRNA species show a retained intron in normal mouse
T cells. The 3′SS ratio data shown in Figure 1 suggest
that up to 13% of all introns in polyadenylated mRNA
remain unspliced in more than 10% of the correspond-
ing mRNAs (3′SS ≥0.1). A smaller subset of introns
(0.94% of all introns) remain unspliced in more than
50% of the mRNAs that contain them. We therefore
asked if exons observed with a retained flanking intron
commonly undergo alternative splicing, by generating a
list of exons that had a 3′SS ratio ≥0.1 in wild-type CD8
T cells from OT1 mice. In total, 6,797 exons had a 3′SS
ratio greater than 0.1, derived from 3,248 genes (Figure 4,
Table 1). The median intron retention (IR) ratio in de-
tectable genes was 0.019 in wild-type T cells. When
compared with annotated alternative exons in the
Ensembl mouse gene set [26] (NCBIM37, Ensembl re-
lease 67), this list showed a highly significant, non-
random overlap with the alternative splicing categories
of cassette exons, mutually exclusive exons and intron
retention (according to the nomenclature of [27])
whereas constitutive exons were found significantly less
than expected (permutation P-value = 0.001; Figure 4,
Table 1). The alternatively spliced Ptprc exons 4 and 6that are skipped in Hnrpll wild-type T cells had a 3′SS
ratio of 0.7 and 0.5, respectively, placing them within the
top 8% of all exons ranked by largest 3′SS ratio. Hence,
3′SS ratios as a simple measure of intron retention can
be used to enrich for mammalian exons that undergo
physiological alternative splicing.
Detection of differentially retained introns in Hnrpllthu
mutants
The data presented above imply that binding of
hnRNPLL to exons in pre-mRNAs delays the excision of
flanking introns from polyadenylated mRNA. We there-
fore sought other hnRNPLL-regulated genes using algo-
rithms to detect differential intron retention or exon
exclusion between wild-type and Hnrpllthu CD8+ T cells.
Using the DEXSeq method [28] we compared the rela-
tive intron read counts within each annotated mouse
gene between wild-type and Hnrpllthu CD8+ T cells from
OT1 mice. This identified 138 introns from 114 genes
with significantly different numbers of reads between
wild type and mutant, including intron 6 from the Ptprc
gene, which ranked second most differentially retained
according to P-value (Ptprc introns 3, 4, 5 and 7 were
also within the top six most significantly retained in-
trons; Additional file 1). Intron 1 of the Ctse gene was
more highly retained than all Ptprc introns, and introns
from the Ddb2, Senp2, Trim30a and Atp2c1 genes com-
prised the remainder of the top 10 highest ranked in-
trons by DEXSeq. Visual inspection of reads for these
and other highly ranked genes using the Integrative
Genomics Viewer (IGV) [29] showed clear cases of
differential intron retention between wild-type and
Hnrpllthu T cells, although these were generally less
striking than that observed in Ptprc, most likely due to
these mRNAs being less abundant.
To identify differential exon exclusion we used DEX-
Seq to compare the relative read depths for each exon
within annotated mouse genes between wild-type and
Hnrpllthu T cells, and ranked exons with significant dif-
ferences according to P-value (Additional file 2). Ptprc
exons 4 and 6 were ranked first and second, respectively.
Of the 138 introns with DEXSeq evidence of differential
intron retention above, 18 of these had at least one
flanking exon with evidence of differential exon exclu-
sion. These intron-exon pairs were from the Ptprc,
Degs1, Ms4a6c, Cdc42, Il7r, Ctse, Gimap8, Slfn1, Rpl29,
Mrpl3 and Ighg2c genes.
As a third method to identify hnRNPLL-regulated spli-
cing events, we surveyed differential splice junction
usage. We used DEXSeq to compare the reads aligned
to all splice junctions between wild-type and Hnrpllthu
T cells, which found 588 significant junctions out of
230,416 in total (at a false discovery rate of 0.1), three-
quarters of which show increased usage in T cells from
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Figure 4 Intron retention ratio is correlated with cassette exon, mutually exclusive exon and intron retention splicing events.
Frequency of matched alternative splicing event types in 1,000 random re-sampling exons representing the background distribution is compared
with the observed number of each splicing event (highlighted in red dotted line) for the exons with increased intron retention (3′SS IR ≥0.01;
CNE, constitutive exon; CE, cassette exon; MXE, mutually exclusive exon; IR, intron retention; A3SS, alternative 3′ splice site; A5SS, alternative
5′ splice site; Table 1). CE, MXE and IR types are significantly enriched, whereas CNE is significantly reduced compared with background (at false
discovery rate P-value = 0.001). A3SS and A5SS are not found to be enriched.
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sociated with mutant hnRNPLL (Additional file 3).
Among 57 junctions that were equally highest-ranked
with an adjusted P-value of 0, splice junctions that
connect alternative exons in the Ptprc gene were found
with a reciprocal pattern of exon-joining versus exon-
skipping. Junctions joining exon 8 and exon 3, exon 7
and exon 3, exon 7 and exon 5, and exon 5 and exon 3
had higher relative sequence coverage in wild-type TTable 1 Intron retention ratio is correlated with cassette exon
splicing events
Alternative splicing
event type
Number of annotated
events in ENSEMBL for all
exons (n = 38,911)
Number of matc
for exons with 3′
(n = 6,65
CNE 19,513 2,538
CE 8,641 1,936
MXE 1,265 294
IR 3,614 749
A3SS 1,249 208
A5SS 1,242 243
Number of alternative splicing event types mapped within 1) all exons in expressed
the mean number of the event types within randomly sampled exon sets of the sam
exon; IR, intron retention; A3SS, alternative 3′ splice site; A5SS, alternative 5′ splice scells, whereas junctions joining exon 6 and exon 5, exon
5 and exon 4, and exon 4 and exon 3 had higher cover-
age in Hnrpllthu T cells. Of the top ten genes ranked by
evidence of intron retention above, five of these also
contained significant differentially altered splice junction
usage flanking these introns (Ptprc, Ctse, Trim30a, Rab3-
gap2 and Slc12a7).
Figure S1 in Additional file 4 shows a Venn diagram of
the overlap of gene identifiers with significant differential, mutually exclusive exon and intron retention
hed events
SS IR ≥0.10
8)
Mean number of matched events
in background (1,000 × re-sampling
6,658 exons from 38,911)
Permutation
P-value
3,338 0.001
1,479 0.001
216 0.001
620 0.001
213 0.636
213 0.009
genes and 2) exons having at least 10% of intron retention in their 3′SS, and
e size. CNE, constitutive exon; CE, cassette exon; MXE, mutually exclusive
ite.
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tion ratios. While a total of 9 genes (Ptprc, Ctse, Ighg2c,
Wdr82, Ms4a6c, Gnai2, Pik3r4, Degs1, Rrp9) have signifi-
cant differential intron retention, exon inclusion and al-
tered splice junction usage (and another 51 with just two
of these features), they are a minority compared with the
total count of genes with one of these features. Hence, ei-
ther methodology issues and noise in the RNA-seq data
may hamper the identification of alternative splicing
events associated with intron retention, or intron reten-
tion may not always be associated with alternative splicing.
It seems plausible that intron retention induced by
hnRNPLL binding may delay splicing of certain introns,
but may not ultimately alter the splicing fate of the pre-
mRNA molecule.
hnRNPLL-dependent splicing in mouse T cells
The preceding analysis was validated in the sense that it
identified known hnRNPLL-dependent splicing events in
Ptprc, so we used reverse transcriptase polymerase chain
reaction (RT-PCR) to validate highly ranked splicing
events in other genes. Ten candidate alternative exons
from distinct genes were selected, choosing those genes
that ranked highly in one or more of the tests described
in the previous section, and showed a clear differential
pattern of read distribution between cell types when
inspected visually using the IGV [29]. Oligonucleotides
complementary to flanking exons were used to amplify
PCR products from oligo-dT-primed cDNA prepared
from Hnrpllwt and Hnrpllthu mRNA, and the products
analyzed by gel electrophoresis (Figure 5). In addition
to Ptprc as a positive control, six of the ten candidate
genes, Senp2, Ctse, Trpv2, Ash1l, Slc12a7, Lck, displayed
differential band sizes or multiple bands that differed
between T cells with normal or mutant hnRNPLL
(Figure 5). Interestingly, these genes all showed evidence
for differential exon usage, but none showed bands at-
tributable to retention of a long intron. This likely can
be attributed to PCR bias towards shorter products and
long intron-containing transcripts not being amplified,
which is a bias not shared with RNA-seq. Alternative
splicing events found in only three of these genes (Ptprc,
Trpv2, Slc12a7) are currently identified by mouse
expressed sequence tags (ESTs) from GenBank [30], in-
dicating the need for more comprehensive annotation of
alternative splicing by RNA-seq studies.
Browsing the RNA-seq reads data for these genes with
IGV indicated that, like Ptprc, three genes (Senp2, Ctse,
Slc12a7) appeared to have greater intron retention in
wild-type cells than in Hnrpllthu T cells, whilst the con-
verse was true for two other genes (Trpv2, Ash1l) and
indeterminate for one (Lck) (Figure S2 in Additional
file 4). High intron retention and exon skipping occurred
in wild-type T cells for Senp2 and Ctse; for Ash1l andSlc12a7, however, high intron retention in Hnrpllwt T
cells was associated with exon inclusion. This indicates
that either hnRNPLL binding can have both a splicing
repressor and enhancer role in wild-type cells, or that
potentially some of these genes are indirectly regulated
by hnRNPLL or are regulated in concert with another
RBP. For all validated candidate genes, the observed al-
ternative splice junction usage from RNA-seq reads sup-
ports the alternative products observed with PCR.
For three candidate hnRNPLL targets (Senp2, Ctse and
Ash1l) the alternative junctions detected by RNA-seq
were outside the significance threshold applied in the
DEXSeq analysis (Figure S2 in Additional file 4). Notable
from the RNA-seq data for these genes was the enrich-
ment of cryptic junction reads. Generally, cryptic splice
sites are rare in the RNA-seq data, but four genes
(Senp2, Ctse, Trpv2, Slc12a7) had a diverse number of
cryptic splice junctions in their retained introns and
flanking the identified alternative exons. Another feature
of these differentially spliced genes was minor unanno-
tated alternative exons. Senp2, Ash1l and perhaps
Slc12a7 and Trpv2 have differentially included alterna-
tive exons that lie within retained introns. Within Senp2,
a differentially included, unannotated, alternative exon
appears in Hnrpllthu cells, which is only present at trace
levels in wild type. Further investigation of this cryptic
exon in Senp2 by sequencing PCR bands showed that it
was included in variable lengths with alternative 3′
splice sites (Figure S3 in Additional file 4). Inclusion of
this cryptic exon introduced an in-frame stop codon that
we estimated caused 23% of the protein to be truncated
in Hnrpllthu cells (calculated as the percentage of cryptic
junctions compared with canonical junctions).
By combining each of the features of hnRNPLL-
dependent alternative splicing events observed above,
we developed a simple scoring scheme based on the sum
of Boolean values for each feature (Table 2). These fea-
tures were intron retention, exon exclusion and splice-
junction usage (determined by DEXSeq) along with the
presence of cryptic junctions and high 3′- or 5′SS ratios.
We scored all introns by these features and ranked them
accordingly. Ptprc and four other PCR-validated genes
(Senp2, Ctse, Ash1l, Slc12a7) ranked within the top 25,
while Trpv2 and Lck ranked 63 and 164, respectively. A
further 136 genes had introns with scores that ranked
them among the validated genes and were likely candi-
dates for hnRNPLL-dependent splicing. We selected 15
of these candidate genes after visual inspection of the
RNA-seq read data with IGV and conducted further RT-
PCR validation of alternative splicing. The results identi-
fied 8 of these 15 genes (Degs1, Sidt1, Mapkapk3, Herc3,
Ikbke, Cep110, Mllt6, Rap1gds1) with differential band
sizes between hnrpllwt and hnrpllthu T cells (Figure 6).
Table 2 shows the scoring matrix of Boolean values of
Figure 5 (See legend on next page.)
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Figure 5 Altered mRNA splicing between wild-type and mutant Hnrpll CD8+ T cells validated with RT-PCR. A selection of ten genes that
ranked highly in one or more tests for differential alternative splicing in Hnrpllthu T cells were validated using RT-PCR. Six genes showed differential
PCR bands between samples and are show alongside an ideogram of the inferred sequence included in each product, determined from band
sizes and the expected included sequence indicated by RNA-seq junction read information. (a) Ptprc gene, oligonucleotide PCR primers located
in exons 2 and 7, amplifying across the regions of alternative exons 4, 5 and 6. (b) Senp2 gene, primers located in exons 8 and 11, amplifying the
intron between exons 10 and 11 containing a variably included unannotated or cryptic exon. The sequence of each band in the accompanying
ideogram was confirmed by Sanger sequencing. (c) Ctse gene, primers located in exon 1 and 2, amplifying unannotated exon in intron 1.
(d) Trpv2 gene, primers located in exons 1 and 3 to amplify unannotated exons in introns 1 and 2. (e) Ash1l gene, primers located in exons 20
and 21, spanning variably included unannotated exon in intron 20. (f) Slc12a7 gene, primers located in an alternative first exon, such that
preference to the other first exon there would be no product. (g) Lck gene, primers were designed with a forward primer spanning across exons
1 and 4 and a reverse primer in exon 5, amplifying products of exon 1 and 4 joining (skipping exons 2 and 3) with variable length of exon 4.
Oligonucleotide primer locations are displayed against read depth and gene intron/structure in Figure S2 in Additional file 4. WT, wild type.
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these genes and those identified earlier, gene set enrich-
ment analysis did not indicate significant shared Gene
Ontology terms, common pathways or other functional
annotations.
Normally spliced Senp2 cDNA restores Hnrpllthu T-cell
survival
The lifespan of Hrnpllthu homozygous T cells is greatly
shortened, resulting in decreased numbers of naïve T
cells in the circulation [16] due to effects on hnRNPLL
targets other than Ptprc [22]. We focused on Senp2 as
an additional candidate, since it was highly ranked and
validated with strong evidence of intron inclusion and
cryptic splicing that would decrease the pool of normal
Senp2 protein in the analysis of Hrnpllthu homozygous
OT-1 T cells above, and because it is an essential regula-
tor of protein sumoylation with the capacity to affect
many aspects of cell survival in non-lymphoid cells
[31,32]. OT-1 CD8 T cells with wild-type or homozygous
mutant Hnrpll were activated briefly in culture, trans-
duced with a retroviral vector encoding normally spliced
Senp2 cDNA or an empty vector control, and re-
implanted into normal C57BL/6 mice. Individual trans-
ferred CD8 T cells were enumerated in blood samples
collected from the recipients on day 3 and again on day
17, using flow cytometric staining for a donor-specific
CD45.1 marker (Figure 7a). Wild-type T cells transduced
with Senp2 or empty vector were frequent in the circula-
tion on day 3, and persisted at 40% of this frequency on
day 17. Hnrpll mutant T cells transduced with empty
vector were less frequent on day 3, and had declined to
11% of this frequency by day 17, consistent with previ-
ous evidence that these T cells have a very short in vivo
lifespan [16]. By contrast, mutant T cells transduced with
Senp2 vector were present at higher frequency on day 3
and persisted at 45% of this frequency by day 17. Im-
proved survival of Hnrpll mutant T cells transduced with
Senp2 compared with control vector, but not of Hnrpll
wild-type T cells transduced with the same vector com-
bination, was observed in two independent experiments(Figure 7b). Flow cytometric staining of the persisting
Hnrpll mutant T cells showed that they nevertheless
continued to be unable to silence Ptprc exon 6, display-
ing 10 times higher CD45RC on their cell surface com-
pared with the transferred wild-type T-cell controls
(Figure 7c). This result, together with isolation of an
ENU-induced exon 10-11 splicing mutation in Senp2
that also results in shortened T-cell survival (Yan Mei,
Anselm Enders, Edward M Bertram and Christopher C
Goodnow, unpublished observations), provide evidence
that Senp2 is an important functional target for Hnrpll-
dependent T-cell survival.
Discussion
Our study develops a strategy for identifying regulated
mRNA splicing events with RNA-seq of total polyA +
RNA, using one of the best defined mammalian models of
developmentally regulated alternative splicing in the Ptprc
gene and a mutation that cripples hnRNPLL, a key RBP
regulating this event. We have shown that introns flanking
the excluded exons in this gene are retained in oligo-dT
primed cDNA from T cells that express hnRNPLL,
whereas these introns are efficiently spliced out of most of
the mRNA in lymphocytes with defective or naturally low
expression of hnRNPLL. Intron retention promoted by
hnRNPLL appears to be a general feature of the transcrip-
tome in T cells and we identified and validated a further
14 genes showing a similar pattern of intron retention and
alternative splicing. Functional evidence for the import-
ance of one of the highest-ranked additional targets,
Senp2, was obtained by retroviral cDNA expression restor-
ing survival of Hnrpll-mutant T cells. The computational
methodology we have applied to identify hnRNPLL-
dependent splicing events in comparison between wild
type and mutant cells is readily generalizable to identify
the program of other regulatory RBPs that dictate patterns
of alternative splicing, using small samples of total RNA
that are readily obtained from purified ex vivo subsets of
primary mammalian cell types.
We have shown that partially spliced polyadenylated
mRNAs, rather than being artifacts of RNA-seq data,
Table 2 All candidate hnRNPLL-regulated splicing events prioritized for RT-PCR confirmation
Gene Intron location Feature scores Score Rank
3′SS ratio 5′SS ratio Differential
exon
Differential
intron
Differential
junction
Cryptic
junctions
Ptprc 1:140013603-140014330 1 1 1 1 1 1 6 1
Degs1 1:184207025-184208627 1 1 1 1 1 1 6 2
Ptprc 1:140016744-140019032 1 1 1 1 1 0 5 3
Ptprc 1:140012220-140013530 1 0 1 1 1 1 5 4
Ptprc 1:140019162-140022879 1 0 1 1 1 0 4 6
Slc12a7 13:73870786-73901144 1 0 0 1 1 1 4 7
Slc12a7 13:73901339-73921966 0 1 0 1 1 1 4 8
Ptprc 1:140014472-140016596 1 1 1 1 1 0 5 11
Rab3gap2 1:187087739-187090779 1 0 0 1 1 1 4 13
Il7r 15:9440015-9440865 0 0 1 1 0 1 3 15
Ctse 1:133535135-133558452 0 0 1 1 0 1 3 16
Sidt1 16:44258155-44259545 0 0 0 1 1 1 3 17
Il7r 15:9438538-9439920 0 0 1 1 0 1 3 20
Il7r 15:9438114-9438461 0 0 1 1 0 1 3 21
Ash1l 3:88871164-88872908 0 1 0 1 0 1 3 23
Senp2 16:22032238-22036542 1 1 0 1 0 1 4 24
Rnf167 11:70463837-70464265 0 1 0 0 1 1 3 26
D14Abb1e 14:28263236-28272964 0 0 0 0 1 1 2 33
Sept7 9:25104073-25105396 0 0 0 0 1 1 2 37
Mapkapk3 9:107166096-107182976 0 1 0 1 0 1 3 44
Trim68 7:109828211-109828650 1 1 0 0 1 1 4 48
Sigirr 7:148281217-148286377 1 0 0 0 1 1 3 50
Trpv2 11:62388103-62389048 1 0 0 0 1 1 3 62
Herc3 6:58824395-58826482 1 0 0 1 0 1 3 66
Ighg2c 12:114524254-114525607 0 1 1 1 0 0 3 71
Pik3r4 9:105580651-105584514 0 0 0 1 0 1 2 80
Ikbke 1:133162866-133166377 0 0 0 1 0 1 2 83
Cep110 2:35013309-35015767 0 0 0 0 1 1 2 84
Fcrl1 3:87185307-87185682 0 0 0 0 1 1 2 87
Mllt6 11:97538551-97539627 0 0 0 1 0 1 2 104
Rap1gds1 3:138619284-138620373 0 0 0 0 1 1 2 131
Lck 4:129234700-129234869 0 0 0 0 1 1 2 163
Number of alternative splicing event types mapped within 1) all exons in expressed genes and 2) exons having at least 10% of intron retention in their 3′SS, and
the mean number of the event types within randomly sampled exon sets of the same size.
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the retention of introns in these transcripts is a regu-
lated process. Previous studies of nascent mRNA have
employed technically demanding nuclear fractionation
before RNA isolation [7,8,33]. Our results are built on
an emerging literature that demonstrates incompletely
spliced, polyadenylated mRNAs - including unspliced in-
trons 3 to 7 in Ptprc mRNA from macrophages - are fre-
quently retained on chromatin as well as being present
in the nucleoplasm [8,10,33,34]. Incompletely spliced,polyadenylated mRNAs are readily identified in RNA-
seq datasets generated from whole-cell mRNA prepara-
tions [10,35,36] and differential intron retention between
different tissues and cell types has also been observed
[7,13,36]. The cause of the differing intron excision in
these studies is mostly unresolved and may stem from
various factors, including intron length, strength of 5′
splice sites, RNA polymerase II pausing, and the binding
of SR proteins to introns [33]. Our study addresses this
question by establishing a strong correlation between
Figure 6 RT-PCR validation of differential mRNA splicing of genes predicted by the Boolean scoring method. Genes with RNA-seq features
associated with differential exon inclusion and intron retention were scored and ranked alongside a set of seven genes that we validated by RT-PCR to
be differentially spliced. Fifteen genes that ranked by score among these validated cases were selected for further RT-PCR, of which eight also showed
differential banding. These products have been separated by eletrophoresis on acrylamide gels. Alongside each gel picture for each gene is an ideogram
of the inferred sequence of each product, estimated by band size and the expected products predicted by junction read abundance from RNA-seq data.
A single replicate from each genotype only was appraised, and these correspond to wild-type (WT) replicate 2 and thunder replicate 2 in Figure 5.
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(c)
Figure 7 Expression of normally spliced Senp2 cDNA partially restores survival of Hnrpllthu T cells. CD8 T cells from Hnrpll+/+ or Hnrpllthu/
thu OT-1 TCR-transgenic B6.SJL-CD45.1/CD45.2 mice were activated and spinoculated with defective retroviral particles containing either empty
retroviral vector or the same vector bearing full length, normally spliced Senp2 cDNA, and injected into the circulation of normal C57BL/6 mice.
(a) Blood from each recipient mouse was analyzed by flow cytometry 3 and 17 days later, enumerating the frequency of donor CD45.1+ T cells
among CD8 cells at each timepoint and the percentage that survived between days 3 and 17. (b) Data from two independent experiments
analyzed as in (a). (c) Staining of the donor-derived T cells for CD45RC: black and blue histograms, +/+ cells with empty or Senp2 vectors,
respectively; red histogram, thu/thu cells with Senp2 vector.
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variably spliced exons, and by experimentally demonstrat-
ing the action of a developmentally regulated, RNA-
binding splicing silencer, hnRNPLL. Nuclear fractionation
and sequencing of nascent, chromatin-associated tran-
scripts and those from the nucleoplasm will provide a
higher degree of sensitivity for detecting unspliced tran-
scripts, but the high quantity of input material required is
unfeasible for cells of limited abundance. The diversity of
RBPs in mammalian cells allows strong cell-type-specific
regulation of splicing, as we have found, and produces an
imperative to compare purified cell populations, which will
frequently mean that starting cells will be in limited supply.
Along with this simple means of generating data we
have developed a scoring and ranking scheme to identify
genes displaying properties associated with regulated in-
tron retention and alternative splicing. No single feature
of exon inclusion, intron retention or splice junction
usage was solely sufficient to reliably identify a group of
transcripts as undergoing regulated late splicing, but asimple integration of evidence from RNA-seq data could
better rank genes. From a set of six genes with RNA-seq
and RT-PCR evidence for differential splicing between
wild-type and thunder Hnrpll mRNAs, we identified that
cryptic junction reads are a frequent feature of introns
flanking alternative exons. Machine learning approaches
are often used to take information about a training set of
genes to extrapolate further similar cases across a large
dataset. We applied a naïve Bayesian classifier to use these
six genes to identify further targets of hnRNPLL regula-
tion. Perhaps due to the small number of training genes
we found the classifier did not produce a list of genes with
convincing evidence on visual inspection of the RNA-seq
data in IGV. As more studies elucidate the features of al-
ternatively spliced genes regulated by RBPs, a greater
number of known, training genes may enable better use of
machine learning algorithms.
Regulated retention of introns flanking alternative
exons in the Ptprc gene indicates that splicing decisions
are frequently delayed until after transcription and
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splicing is that it provides more (or later) opportunities
for regulated alternative splicing [10]. The retained in-
trons we have observed in the Ptprc gene do not appear
to be ‘dead-end’ transcripts destined for degradation,
but are likely exons on which a splicing decision is pend-
ing. Speculatively, delayed processing of variable exons in
Ptprc may provide a pool of mRNA that can be rapidly
modified in response to changing extracellular signals.
This paradigm is perhaps best demonstrated by the un-
conventional cytoplasmic splicing of Hac1/Xbp1 mRNA
in response to endoplasmic reticulum stress [37], but has
also been suggested for conventional alternative splicing
[13]. While there is no direct evidence to support this pos-
sibility for Ptprc, TCR-induced dephosphorylation of PSF1
promotes Ptprc exon silencing [38]. Potentially, this pool
of ‘delayed transcripts’ are awaiting a cellular decision on
the splicing of alternative exons. In the absence of this de-
cision introns surrounding the alternative exons remain
unspliced, to allow the option of a splicing event that
causes an exon to be skipped.
The differentially spliced genes between wild-type and
thunder T cells elucidate the primary or secondary tar-
gets of hnRNPLL and identify a cellular program that is
likely to be specifically regulated between naïve and acti-
vated/memory T cells. Both SR proteins and hnRNPs are
encoded by large gene families and the diversity of these
proteins allows highly tissue-specific splicing regulation
by single RBPs [39]. Hence, we need not expect a large
number of hnRNPLL-dependent targets. However, apart
from these genes all being co-expressed in T cells, there
are few annotations that obviously link them functionally
as a larger program. Several pairwise functional associa-
tions are clear, such as the well characterized direct
interaction of CD45 with LCK to dephosphorylate pTyr-
505 and pTyr-394 regulatory tyrosines on LCK [40,41].
One hypothesis to explain this apparent lack of a
broader program may be that the true functional targets
of hnRNPLL are indeed a very small set, perhaps being
just one, two or three genes. Functional associations be-
tween these genes will not be effectively captured
through gene set enrichment analysis, as gene pairs or
trios will be statistically very sensitive to missing or in-
complete functional annotations. The differential exon
usage in the Ptprc gene is the clearest signal seen in the
RNA-seq data and the signal of the other genes is much
less distinct, and decreases quickly to the limit of detec-
tion through our positive gene list. It could be that genes
with weaker signals represent minor or promiscuous
binding targets of hnRNPLL without strong functional
effect. Of the stronger targets, namely those in our first
list of six high ranking gene targets, it will be important
to investigate the functional impact of the splicing regu-
lation mediated by hnRNPLL. We provide evidence herethat inefficient splicing of one of these targets, Senp2,
contributes to the short lifespan of hnRNPLL-mutant T
cells. Senp2 encodes a sumo-specific protease and results
in embryonic lethality when knocked out [31,32], but
how it promotes T-cell longevity will await further study.
Detection of genes with differentially retained introns
from RNA-seq data suggests a method for mapping the
targets and extended regulatory program of hnRNPs and
potentially some SR proteins. This approach identifies
both direct and secondary targets of RNA binding pro-
teins, and hence would be highly complementary to add-
itional sources of information from RIP-seq, PAR-CLIP
and other immunoprecipitation followed by sequencing
approaches. Collections of mice with knockout and mu-
tant hnRNPs are steadily growing and transcriptome
data taken from appropriate cells could be extracted, se-
quenced and mined using a technically simple approach
similar to that presented here. For example, hnRNPLL
and hnRNPL have overlapping roles in regulating the
splicing of Ptprc in T cells [42]. With existing mouse
knockouts for hnRNPL, mapping of the functional tar-
gets of RBPs could be undertaken similarly to this study,
in combination with genome-wide RNA-binding assays.
Conclusions
Collectively, our data indicate that lymphocytes that ex-
press wild-type hnRNPLL at high levels (wild-type T cells)
exhibit a delay in splicing of the Ptprc introns surrounding
those exons (exons 4 and 6) with multiple hnRNPLL bind-
ing sequences, so that 8 to 20% of mRNA retains these in-
trons after they have spliced out most other introns and
become polyadenylated. This provides in vivo genetic
evidence in mammalian cells that intron processing is
delayed around alternatively spliced exons in nascent
mRNA, whereas it often occurs co-transcriptionally and
preceding polyadenylation for introns associated with con-
stitutively spliced exons, consistent with emerging obser-
vations in other systems [7,8,33].
Materials and methods
RNA preparation
Single cell suspensions of mouse spleens were prepared
by sieving and gentle pipetting followed by lysis of red
blood cells. CD8+ T cells were isolated to >90% purity
(as assessed by flow cytometry) using mouse CD8α
microbeads (Miltenyi Biotec Australia Pty. Ltd. NSW,
Australia) following the manufacturer’s instructions.
Total RNA was then extracted using TRIzol (Invitrogen™
Life Technologies Australia Pty. Ltd. Victoria, Australia)
and isopropanol precipitation. The purity and integrity
of RNA was determined using the Agilent Bioanalyzer,
which reported an RNA integrity number of >8.5 for
all samples. CD19+ B cells and CD4+ T cells were puri-
fied from spleens of wild-type C57BL6 mice using
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CD4 antibodies.
Sequencing and mapping
Sequencing was done using an Illumina GAIIx with a
single-end length of 125 bp for OT1 samples and 76 bp
for non-OT1 samples. RNA-sequencing reads were
aligned to the mouse reference genome mm9 (NCBIM37)
using TopHat (v1.4.1) with Bowtie by using default pa-
rameters, which allows up to two mismatches [23]. Mean
base coverage of an intron or exon was calculated as fol-
lowing: Number of reads mapped × Read length/Feature
length. Gene expression was estimated from all reads
mapping to all exons annotated to a gene. A minimum
average coverage threshold of 20 bases was used to desig-
nate genes as expressed. The raw sequencing data have
been uploaded to NCBI Short Read Archive under acces-
sion number SRP034881.
Detection of differential splicing
Identification of differential inclusion of introns, exons
and/or splice junctions was done using the DEXSeq pack-
age (version 1.8.0 on R version 3.0.2) [28], which normal-
izes count data for different coverage depths and
estimates data dispersions, then tests for differential in-
tron/exon/junction usage between wild type and mutant
using a generalized linear model. An input dataset of non-
overlapping exonic parts of the mm9 genome was created
by the script dexseq_prepare_annotation.py provided in
the package based on the Ensembl transcript annotation
file Mus_musculus.NCBIM37.66.gtf, which was used to
create a table of intronic parts for multi-exon genes. For
more sensitive detection of differential reads within long
introns, introns were further divided into 300 bp windows.
The dexseq_count.py script, also part of the DEXSeq
package, was then used to count the number of reads that
fall within each exon or intron. Analysis of differential
exon and intron inclusion were performed on both fea-
tures simultaneously with DEXSeq (Additional file 5). As
most introns contain few or no reads and pooling the data
in this manner allowed better normalization. Dispersion
estimation and statistical model calculation was per-
formed using the TRT method provided with DEXSeq on
exons and introns with a minimum of 10 counts over all
samples. A raw splicing junction count dataset was gener-
ated using TopHat and was used in DEXSeq analysis
to find differential splice junction usage for junctions of
a minimum count of 2 over all samples. At a false discov-
ery rate of 0.1, 558 out of 230,416 junctions were found to
be significant.
Calculation of intron retention ratio
Intron retention ratios across 5′ and 3′ splice sites were
calculated as the sum of reads mapped to 25 bpupstream and downstream of the splice site, and calcu-
lated as the ratio of intronic reads to exonic reads, as
previously described [7].
Retained introns and annotated alternative splicing
events
Exons associated with high 3′- or 5′SS read ratios were
compared to alternative splicing events annotated to the
Ensembl mouse gene set [26] (NCBIM37, Ensembl release
67). Annotated alternative splicing event types included
constitutive exon (CNE), cassette exon (CE), mutually ex-
clusive exons (MXE), intron retention (IR), alternative 3′
sites (A3SS), and alternative 5′ sites (A5SS) after the no-
menclature described in [43]. A frequency of each splicing
event type was calculated for exons that had a 3′SS ratio
≥0.01 in wild-type T cells from OT1 mice, then compared
with 1,000 randomly permuted sets for each type of spli-
cing event. P-values were calculated for a null hypothesis
that the frequencies of splicing event types in exons hav-
ing at least 10% of intron retention are not different to a
background distribution, with an alternative hypothesis
that the frequencies in exons of increased 3′SS IR is
higher for event types CE, MXE, IR, A3SS, and A5SS and
lower for the CNE type.
Scoring scheme to rank differential intron retention
events
Six measures related to differential intron retention were
calculated: differential exon inclusion, differential splice
junction usage, differential intron retention, distinct
cryptic splice sites (per intron) and 3′- and 5′SS ratios.
Differential exon, intron and splice junction read tests
were calculated with DEXSeq as described above and
features were scored ‘true’ if they were below a signifi-
cance threshold equivalent to a false discovery rate of
less than 0.1. Cryptic junctions were scored as ‘true’ if
they had more than one unannotated junction supported
by three or more reads in at least one sample. 3′- and 5′
SS ratios were calculated as described above and these
ratios compared between cells types. Where ratios dif-
fered by 0.1 or more, these were scored as ‘true’. Across
all six feature types true values were summed and in-
trons ranked according to total score.
PCR validation of candidate genes
RNA samples from OT-1 CD8+ T lymphocytes from
spleen of wild-type and thunder mice were prepared as
described above then reverse transcribed to produce
first-strand cDNAs (Marligen Biosciences, Ijamsville,
MD, USA). cDNA products were quantified with a
Nanodrop Spectrophotometer and used for PCR amplifi-
cation of candidate genes using Taq DNA polymerase
with a 55°C annealing temperature and 35 cycles, which
were then electrophoresed in 2% agarose gel or 4%
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respectively. Primer sequences used for validation of
alternative splicing variants are shown in Table S4 in
Additional file 4.OT-1 T cell transduction and transplantation
CD8 T cells were purified by magnetic bead depletion of
other lymphocyte subsets from spleens of OT-1 TCR
transgenic B6.SJL-CD45.1 congenic mice of Hnrpll+/+ or
Hnrpllthu/thu genotype. The T cells were activated by cul-
ture at 2 × 106 cells/ml with plate-bound anti-CD3 and
soluble anti-CD28 antibodies for 24 h, and then spinocu-
lated with defective retroviral particles packaged in
Phoenix cells containing either empty pMIG II vector or
the same vector bearing full length normally spliced
Senp2 cDNA. The T cells were placed back in culture
with anti-CD3 and anti-CD28 for 24 h, washed, and
injected into the lateral tail vein of normal C57BL/6
mice. Each recipient mouse was bled 3 and 17 days later,
blood cells stained for CD8, CD45.1 and CD45RC, and
analyzed by flow cytometry.Additional files
Additional file 1: Table S1. Table of differential intron usage found by
DEXSeq.
Additional file 2: Table S2. Table of differential exon usage found by
DEXSeq.
Additional file 3: Table S3. Table of differential junction usage found
by DEXSeq.
Additional file 4: Figure S1. A Venn diagram of genes with features
(exon/intron/junction) found significant by DEXSeq. DEXSeq tests for
finding differential exon, intron and junction inclusion resulted in a total
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